Related Experiment Video

Updated: Aug 6, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

Dendritic cells and tumor microenvironment: a dangerous liaison

Ingo Fricke1, Dmitry I Gabrilovich

  • 1H. Lee Moffitt Cancer Center, University of South Florida, Tampa, Florida 33612, USA.

Immunological Investigations
|August 19, 2006
PubMed

Insights

Cancer immunotherapy is limited by a suppressed immune response. This review explores how the tumor microenvironment impairs dendritic cell (DC) function, hindering anti-tumor immunity.

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • The host immune system's unresponsiveness is a key mechanism of tumor escape and limits cancer immunotherapy success.
  • Inadequate function of dendritic cells (DCs), professional antigen-presenting cells, is a major factor in compromised anti-tumor immunity.
  • Despite progress, the precise mechanisms behind DC dysfunction in cancer remain unclear.

Purpose of the Study:

  • To review the potential role of the tumor microenvironment in dendritic cell (DC) dysfunction within the context of cancer.

Main Methods:

  • This is a review article, synthesizing existing research on the tumor microenvironment and DC function in cancer.

Main Results:

  • The tumor microenvironment is increasingly recognized as a significant contributor to DC malfunction in cancer.
  • Understanding these microenvironmental factors is crucial for developing effective cancer immunotherapies.

Conclusions:

  • The tumor microenvironment plays a critical role in DC dysfunction, impacting anti-tumor immune responses.
  • Further research into the tumor microenvironment's influence on DCs is essential for advancing cancer immunotherapy strategies.

More Related Videos

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Antigen Presenting Cells01:22

Antigen Presenting Cells

The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...